Aaron Kantoff is an experienced professional who has held various board member and partner positions in multiple biotech companies. Currently serving as Co-Founder & Managing Partner at Scion Life Sciences and as a Board Member at Tourmaline Bio, Aaron is focused on developing transformative medicines for patients with immune & inflammatory diseases. Aaron has also been involved in companies like RayzeBio, Centessa Pharmaceuticals, and Elstar Therapeutics Inc., contributing to the growth and success of each organization. With a background in Finance and International Business from New York University, Aaron has made significant contributions to the biotech industry.
Current role